AngioDynamics Inc (ANGO, Financial) files its latest 10-K with SEC for the fiscal year ended on May 31, 2018. AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. AngioDynamics Inc has a market cap of $797.540 million; its shares were traded at around $21.67 with a P/E ratio of 49.25 and P/S ratio of 2.35. AngioDynamics Inc had annual average EBITDA growth of 1.10% over the past ten years.
For the last quarter AngioDynamics Inc reported a revenue of $88.3 million, compared with the revenue of $86.91 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $344.3 million, a decrease of 1.5% from the previous year. For the last five years AngioDynamics Inc had an average revenue decline of 0% a year.
The reported diluted earnings per share was 44 cents for the year, compared with the loss per share of $0.07 in the previous year. The AngioDynamics Inc had an operating margin of 7.62%, compared with the operating margin of 7.21% a year before. The 10-year historical median operating margin of AngioDynamics Inc is 6.78%. The profitability rank of the company is 5 (out of 10).
At the end of the fiscal year, AngioDynamics Inc has the cash and cash equivalents of $74.1 million, compared with $47.5 million in the previous year. The long term debt was $86.6 million, compared with $91.3 million in the previous year. The interest coverage to the debt is 8.6. AngioDynamics Inc has a financial strength rank of 7 (out of 10).
At the current stock price of $21.67, AngioDynamics Inc is traded at 40.9% premium to its historical median P/S valuation band of $15.38. The P/S ratio of the stock is 2.35, while the historical median P/S ratio is 1.67. The stock gained 36.00% during the past 12 months.
For the complete 20-year historical financial data of ANGO, click here.
